Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

Uma Borate · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
acute myeloid leukemia with flt3/itd mutation, acute myeloid leukemia with kmt2a rearrangement, acute myeloid leukemia with npm1 mutation, recurrent acute myeloid leukemia, refractory acute myeloid leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 852632
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.